Feed aggregator
SPI-M-O: Summary of modelling on scenario for easing restrictions, 7 February 2021
Summary by the Scientific Pandemic Influenza Group on Modelling, Operational sub-group (SPI-M-O).
SPI-M-O: Insights from early vaccination modelling, 9 December 2020
Paper prepared by the Scientific Pandemic Influenza Group on Modelling, Operational sub-group (SPI-M-O).
Imperial College London: Evaluating England’s roadmap out of lockdown, 30 March 2021
Paper prepared by Imperial College London on Step 2 of the roadmap.
SPI-B: Behavioural considerations for maintaining or reintroducing behavioural interventions and introducing new measures in autumn 2021, 14 October 2021
Paper prepared by the Scientific Pandemic Insights Group on Behaviours (SPI-B).
Adult social care in England, monthly statistics: May 2022
Experimental statistics on a range of topics including infection control measures, vaccinations and coronavirus (COVID-19) testing in adult social care settings.
Vaccine update: issue 328, May 2022, Shingrix® special edition
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
Vaccine update: issue 327, May 2022, SCID, TB and BCG special edition
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
Immunoglobulin: when to use
UK Health Security Agency's immunoglobulin handbook, providing guidance on administering immunoglobulin to prevent serious disease.
Commission on Human Medicines – Membership
Membership and minutes for the Commission on Human Medicines (CHM) and its expert advisory groups (EAGs).
UKHSA appoints non-executive members to its board
The UK Health Security Agency (UKHSA) has appointed 5 non-executive members and 3 associate non-executive members to its management board.
Freedom of Information responses from the MHRA - week commencing 2 August 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 2 August 2021
Freedom of Information responses from the MHRA - week commencing 4 October 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 4 October 2021
Vaccine update: issue 326, April 2022, HPV special edition
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
National flu immunisation programme plan 2022 to 2023
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
MHRA approves the Moderna COVID-19 vaccine ‘Spikevax’ for use in 6 to 11-year olds
Use of the Moderna COVID-19 vaccine or ‘Spikevax’ has been approved for 6 to 11s after meeting the required safety, quality and effectiveness standards
Adult social care in England, monthly statistics: April 2022
Experimental statistics on a range of topics including infection control measures, vaccinations and coronavirus (COVID-19) testing in adult social care settings.
Coronavirus (COVID-19) vaccines adverse reactions
A weekly report covering adverse reactions to approved COVID-19 vaccines
Changes to Human Medicine Regulations to support the rollout of vaccines: one-year review
A report summarising the findings following a one-year review of the use of regulations 174A and 247A, implemented to support the rollout of COVID-19 and flu vaccines.
DHSC non-executive appointments
Information about non-executive appointments to the Department of Health and Social Care's public bodies and committees.
Intergovernmental Relations Review Annual Report for 2021
Annual report on intergovernmental relations and working in 2021.
Pages
